Cargando…
Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged ≥55 Years in the SEER-Medicare Population
Our study evaluated whether 1999 National Cancer Institute (NCI) chemoradiation guidelines for cervical cancer impacted treatment of women ≥55 years. We identified 385 women ≥55 years (median, 72 years) diagnosed with stage II-IVA cervical cancer between January, 1998 and December, 2002 in the Unite...
Autores principales: | Kunos, Charles, Gibbons, Heidi, Simpkins, Fiona, Waggoner, Steven |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648643/ https://www.ncbi.nlm.nih.gov/pubmed/19259335 http://dx.doi.org/10.1155/2008/931532 |
Ejemplares similares
-
Effects of surgery, chemotherapy, and radiation on hepatocellular carcinoma patients: A SEER-based study
por: Qayum, Kaif, et al.
Publicado: (2021) -
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
por: Garcia‐Soto, Arlene E., et al.
Publicado: (2021) -
Comparison of SEER Treatment Data With Medicare Claims
por: Noone, Anne-Michelle, et al.
Publicado: (2016) -
Overview of the SEER—Medicare Health Outcomes Survey Linked Dataset
por: Ambs, Anita, et al.
Publicado: (2008) -
Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016
por: Chhatre, Sumedha, et al.
Publicado: (2022)